Five days later, Cole had a severe asthma attack, stopped breathing and collapsed. According to his family, he suffered ...

The albuterol sulfate metered dose inhalers market will continue its strong growth over the next few years, estimated to reach $7.19 billion in 2029, with a CAGR of 8.5%.

Dublin, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The "Albuterol Sulfate (CAS 51022-70-9) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ...

This report on Albuterol sulfate provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological ...

Man Dies of Fatal Asthma Attack After Meds Jumped to Over $500, Lawsuit Alleges — Parents' lawsuit alleges PBM violated Wisconsin law by raising cost without valid medical reason ...

The Lupin share traded almost 5 percent low on May 23 afternoon on worries of increased competition for its Albuterol Sulfate inhalation aerosol in the US market.

Lupin shares tumbled up to 7%, bogged down by an increased competition in Albuterol Sulfate Inhalation Aerosol in the US. Albuterol is the second largest revenue contributor to the US revenue of Lupin ...

Amphastar plans to launch its Albuterol Sulfate Inhalation Aerosol in the third quarter of 2024.

The FDA determined that Amphastar's albuterol is bioequivalent and therapeutically equivalent to Teva Respiratory LLC's ProAir ® HFA (albuterol sulfate) Inhalation Aerosol.

A man holds an albuterol sulfate inhaler, commonly used in the treatment of asthma as a reduce inhaler for acute asthma attack. Children could face a shortage of inhalers now that Medicaid updated ...